Miller Richard A Md (CIK 0001031847)

Latest company ownership

Shares held
577,634
Last filed at
May 14, 2024
Confidence Score
50.0
2025Q4
Confidence Score History
2016Q2 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
May 6, 2024 May 7, 2024 Corvus Pharmaceuticals, Inc. CEO Buy 97.5 +577,634 38.76% ✗ $1M
Dec 13, 2022 Dec 15, 2022 Corvus Pharmaceuticals, Inc. CEO Buy 83.8 +60,000 4.20% ✗ $44.8K
Sep 28, 2022 Sep 28, 2022 Corvus Pharmaceuticals, Inc. CEO Buy 78.8 +25,000 1.78% ✗ $19.1K
Sep 20, 2022 Sep 20, 2022 Corvus Pharmaceuticals, Inc. CEO Buy 78.8 +20,000 1.44% ✗ $16.3K
Jun 24, 2022 Jun 28, 2022 Corvus Pharmaceuticals, Inc. CEO Buy 68.8 +10,000 0.73% ✗ $10.1K
Jun 2, 2022 Jun 6, 2022 Corvus Pharmaceuticals, Inc. CEO Buy 60.0 +5,890 0.43% ✗ $5.8K
Mar 31, 2022 Apr 1, 2022 Corvus Pharmaceuticals, Inc. CEO Buy 78.8 +15,000 1.11% ✗ $24.5K
Mar 15, 2022 Mar 17, 2022 Corvus Pharmaceuticals, Inc. CEO Buy 78.8 +30,000 2.27% ✗ $44.6K
Aug 20, 2021 Aug 23, 2021 Corvus Pharmaceuticals, Inc. CEO Buy 68.8 +10,000 0.76% ✗ $19.3K
May 4, 2021 May 5, 2021 Corvus Pharmaceuticals, Inc. CEO Buy 87.5 +35,714 2.79% ✗ $100K
Feb 17, 2021 Feb 17, 2021 Corvus Pharmaceuticals, Inc. CEO Buy 92.5 +100,000 8.49% ✗ $350K
Nov 12, 2019 Nov 14, 2019 Corvus Pharmaceuticals, Inc. CEO Buy 78.8 +15,008 1.29% ✗ $45K
Aug 6, 2019 Aug 8, 2019 Corvus Pharmaceuticals, Inc. CEO Buy 68.8 +7,500 0.65% ✗ $26.7K
Jun 13, 2019 Jun 17, 2019 Corvus Pharmaceuticals, Inc. CEO Buy 78.8 +12,000 1.05% ✗ $40.9K
Jun 7, 2019 Jun 11, 2019 Corvus Pharmaceuticals, Inc. CEO Buy 82.5 +15,212 1.35% ✗ $53K
Dec 27, 2018 Dec 31, 2018 Corvus Pharmaceuticals, Inc. CEO Buy 82.5 +20,000 1.80% ✗ $65.9K
Dec 20, 2018 Dec 26, 2018 Corvus Pharmaceuticals, Inc. CEO Buy 68.8 +10,000 0.91% ✗ $44K
Dec 6, 2018 Dec 10, 2018 Corvus Pharmaceuticals, Inc. CEO Buy 61.3 +5,000 0.45% ✗ $29.9K
Dec 4, 2018 Dec 6, 2018 Corvus Pharmaceuticals, Inc. CEO Buy 55.0 +1,502 0.14% ✗ $8.9K
Mar 12, 2018 Mar 12, 2018 Corvus Pharmaceuticals, Inc. CEO Buy 92.5 +100,000 9.88% ✗ $850K
Nov 20, 2017 Nov 22, 2017 Corvus Pharmaceuticals, Inc. CEO Buy 72.5 +10,000 1.00% ✗ $107.9K
Jun 9, 2017 Jun 13, 2017 Corvus Pharmaceuticals, Inc. CEO Buy 87.5 +25,000 2.56% ✗ $247.1K
May 12, 2016 May 16, 2016 Corvus Pharmaceuticals, Inc. CEO Buy 90.0 +30,300 2.89% ✗ $303K